Affiliation:
1. Universidad de La Sabana. Chía
2. Clínica Universidad de La Sabana
Abstract
Abstract
Background
Information on the performance of oxygenation indices (IO) and risk scores in patients requiring invasive mechanical ventilation (IMV) is limited. We determine the performance of the IOs and risk scores in hospitalized patients with COVID-19 to predict the requirement of IMV and death at 7, 14 and 28 days after admission.
Methods
Retrospective cohort study in patients admitted to the emergency department, hospitalization, and intensive care unit diagnosed with COVID-19 and in whom oxygenation indices were measured within the first 6 hours of admission, between 6 and 12 hours, 12 to 24 hours and greater than 24 hours. The receiver operating characteristic curve (ROC-curve) were built with the OIs and risk scores to predict IMV and mortality.
Results
A total of 1402 subjects entered the final analysis, of whom 19.5% (274/1402) received IMV and 23.0% (323/1402) died at 28 days. In the general population, the mean age was 59.9 years (SD 16.19), the male sex represented 63.3% (888/1402) and the duration from the onset of symptoms was 7.3 days (SD: 13.26). Analysis with the De Long test showed that at 7, 14 and 28 days the ROC-curves with the best performance for IMV were PaO2/FiO2, 4C score, SOFA score and SaO2/FiO2, the ROC curves of the rest of the OI evaluated were lower (p < 0.001). At 28 days, the ROC-curve with the best behavior for death was 4C compared to the ROC-curves of the rest of the OI and risk scores evaluated (p < 0.001).
Conclusion
PaO2/FiO2 ≤ 300, 4C score ≥ 8, SOFA score ≥ 4 y SaO2/FiO2 ≤ 300 were weak predictors of the IMV requirement from admission, and 4C score ≥ 8 was weak predictors of the mortality from admission in patients with pulmonary involvement by COVID-19.
Publisher
Research Square Platform LLC
Reference40 articles.
1. Coronavirus disease 2019 dashboard: World Health Organization; [5-12-22]. Available from: https://covid19.who.int/.
2. Microstructure, pathophysiology, and potential therapeutics of COVID-19: A comprehensive review;Singh SP;J Med Virol,2021
3. Safiabadi Tali SH, LeBlanc JJ, Sadiq Z et al. Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection. Clin Microbiol Rev. 2021; 12;34(3):e00228-20.
4. Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome;Beloncle F;Crit Care,2021
5. Acute respiratory distress syndrome;Meyer NJ;Lancet,2021